No black box warning on record for Ulspira

As of the latest FDA labeling reviewed, Ulspira (ULSPIRA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ulspira medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Rebound Pulmonary Hypertension Syndrome following Abrupt Discontinuation Wean from ULSPIRA [see Dosage and Administration (2.2)]. Abrupt discontinuation of ULSPIRA may lead to worsening oxygenation and increasing pulmonary artery pressure, i.e., Rebound Pulmonary Hypertension Syndrome. Signs and symptoms of Rebound Pulmonary Hypertension Syndrome include hypoxemia, s

No black box warning on record for Ulspira

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Rebound Pulmonary Hypertension Syndrome following Abrupt Discontinuation Wean from ULSPIRA [see Dosage and Administration (2.2)]. Abrupt discontinuation of ULSPIRA may lead to worsening oxygenation and increasing pulmonary artery pressure, i.e., Rebound Pulmonary Hypertension Syndrome. Signs and symptoms of Rebound Pulmonary Hypertension Syndrome include hypoxemia, s

Ulspira Black Box Warning

No black box warning on record for Ulspira

Other warnings & precautions

Ulspira Black Box Warning

No black box warning on record for Ulspira

Other warnings & precautions